Stories > AHF Criticizes Gilead Sciences for Profiteering in Drug Prices

AHF Criticizes Gilead Sciences for Profiteering in Drug Prices

Arcus Biosciences Boosts Inducement Gran...

Arcus Biosciences Employs Inducement Gra...

Arcus Biosciences Enhances Employee Bene...

Acquisition Progress Amid Safety Concern

Amgen's Weight-Loss Drugs Market Entranc...

Analyst Recommendations Impact Diverse C...